BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 17, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 10, 1998
View Archived Issues
MedImmune: Q3 1998 highlights
Read More
Aquila Biopharmaceuticals: Q3 1998 highlights
Read More
Sepracor: Q3 1998 highlights
Read More
MitoKor and Pfizer to collaborate on mitochondrial targets for neurodegenerative diseases
Read More
Two major clinical studies demonstrate chemo- and radioprotective activity of amifostine
Read More
FAME study will evaluate effects of lipid lowering in the elderly
Read More
Sangamo enters agreement with Zeneca for identification of novel gene targets
Read More
BMS to acquire Korean company
Read More
Promising interim results announced for SU-5416 phase I trial
Read More
WAY-135433 increases HDL cholesterol, protects against atherosclerosis and heart disease
Read More
Novel compounds from ADIR acting on the dopaminergic system
Read More
Compounds acting on metabotropic glutamate receptors disclosed by Lilly
Read More
Noncytotoxic thiocolchicine derivatives useful as muscle relaxants
Read More
Canadian team describes cardioprotective activity of AAA-135
Read More
New series from Agouron with inhibitory activity against MMPs and TNF-alpha production
Read More
Pharmacia & Upjohn patents new agents for CNS and neurodegenerative disorders
Read More
Specific MC4 receptor agonist reduces food intake in leptin-deficient and -resistant mice
Read More
LY-203638 has potent profibrinolytic effects in canine model of thrombosis
Read More
Pfizer presents preclinical profile of potent, full 5-HT1D receptor antagonist
Read More
RPR-118723: a novel anticonvulsant and potent glycine-site NMDA receptor antagonist
Read More
Knoll's promising new treatment for RA covered in depth at rheumatology congress
Read More
Reversible mixed MAO-A/MAO-B inhibitor discovered at Synthelabo is presented this week
Read More
Novel sodium channel blocker from Roche evaluated in vitro for neuroprotective efficacy
Read More
NK1 antagonist L-732138 exhibits activity indicating efficacy in neuropathic pain
Read More
Cevimeline improves symptoms of xerostomia in animal models, patients with Sjogren's syndrome
Read More
LEF-553: a potent mu-opioid receptor agonist with peripheral analgesic effects
Read More
Preclinical pharmacokinetics of MEN-11420 determined in rats; compound advances to clinical trials
Read More
Ciba Vision launches Vitravene in the U.S.
Read More
Knoll develops potential new antipsychotic agent with advantages over available therapies
Read More
